- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/185 - Radicals derived from carboxylic acids from aliphatic carboxylic acids
Patent holdings for IPC class C07D 295/185
Total number of patents in this class: 478
10-year publication summary
47
|
39
|
46
|
30
|
29
|
43
|
28
|
26
|
21
|
6
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 19681 |
10 |
F. Hoffmann-La Roche AG | 7889 |
7 |
Board of Regents, The University of Texas System | 5689 |
7 |
Modernatx, Inc. | 1249 |
7 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2822 |
7 |
Boehringer Ingelheim International GmbH | 4732 |
6 |
Rutgers, The State University of New Jersey | 1865 |
6 |
The Scripps Research Institute | 1343 |
6 |
Guangzhou Innocare Pharma Tech Co., Ltd. | 12 |
6 |
Centre National de La Recherche Scientifique | 10202 |
5 |
Aeromics, Inc. | 28 |
5 |
Dongguk University Industry-Academic Cooperation Foundation | 420 |
5 |
Emory University | 1613 |
5 |
Korea University Research and Business Foundation | 2887 |
5 |
PTC Therapeutics, Inc. | 468 |
5 |
University of Pittsburgh - Of the Commonwealth System of Higher Education | 3093 |
5 |
Novartis AG | 11042 |
4 |
Conopco, Inc. | 4910 |
4 |
Genentech, Inc. | 3898 |
4 |
President and Fellows of Harvard College | 5905 |
4 |
Other owners | 365 |